Azenta Life Sciences Company Research Report
Company Overview
Name: Azenta Life Sciences
Mission: Azenta Life Sciences is dedicated to enabling life sciences organizations around the world to bring impactful breakthroughs and therapies to market – faster.
Founded: 1999
Founders: No information is available
Key People:
- John P. Marotta (CEO)
Headquarters: 115 Corporate Boulevard, South Plainfield, NJ 07080
Number of Employees: No information is available
Revenue: No information is available
Known For:
Azenta Life Sciences is known as a global leader in R&D genomics services, offering Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next-generation sequencing, bioinformatics, and GLP regulatory services.
Products
Next Generation Sequencing
- High-level Description: Comprehensive NGS services for varying research needs.
- Key Features: Whole Genome Sequencing, RNA Sequencing, Single Cell RNA Sequencing, Exome Sequencing, ISO-Seq.
Sanger Sequencing
- High-level Description: Reliable DNA sequencing with industry-standard protocols.
- Key Features: Precise DNA sequence analysis suitable for various sample types.
Gene Synthesis
- High-level Description: Custom gene synthesis services for research and industrial purposes.
- Key Features: Codon optimization, targeted gene insertion, synthetic gene creation.
Molecular Genetics
- High-level Description: Broad range of molecular biology techniques.
- Key Features: Cloning, mutagenesis, plasmid preparation, and more.
Clinical Services
- High-level Description: Preclinical and clinical trial support services.
- Key Features: Compliance with GLP, CLIA, and CAP standards, extensive quality management.
Plasmid DNA Preparation
- High-level Description: Custom preparation of plasmid DNA for various applications.
- Key Features: High-quality plasmid DNA suitable for cloning, sequencing, and other downstream applications.
Oligo Synthesis
- High-level Description: Custom synthesis of oligonucleotides.
- Key Features: High purity and precise synthesis of custom oligonucleotides for various research needs.
Recent Developments
Recent Product Launches
- Whole Genome Sequencing: Comprehensive analysis including annotation and exploration of genomic variations.
- RNA Sequencing: Advanced RNA sequencing services including mRNA-mediated delivery of gene editing tools.
New Features Added
- Codon Optimization with Deep Learning: Enhanced protein expression through optimized gene synthesis.
- High Efficiency Cryogenic Freezers: New products aimed at improving cold-chain storage efficiency.
New Partnerships
- AskBio: Collaboration to advance gene therapy technologies.
- Cornell Veterinary Biobank: Partnership to enhance biobank processes and comply with ISO standards.
Notable Events
- Appointment of John P. Marotta as CEO: Leadership change to spearhead future growth (September 4, 2024).
- GENEWIZ Week: Celebration of 25 years of advancing scientific discoveries (August 12, 2024).
- Azenta Q3'24 Earnings Release Conference Call and Webcast: Financial performance update for Q3 FY2024.
This report is based on currently available data and aims to provide a detailed, professional overview of Azenta Life Sciences. Additional specific financial data and some historical founder information are not available in the provided data.
